A Case of Hepaticoduodenal Fistula Development after Transarterial Chemoembolization in Patient with Hepatocellular Carcinoma.
10.4166/kjg.2011.58.3.149
- Author:
Yoon Hea PARK
1
;
Se Hun KANG
;
Seung Up KIM
;
Do Young KIM
;
Jun Yong PARK
;
Sang Hoon AHN
;
Kwang Hyub HAN
;
Chae Yoon CHON
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
- Publication Type:Case Report ; English Abstract
- Keywords:
Hepaticoduodenal fistula;
Hepatocellular carcinoma;
Transarterial chemoembolization
- MeSH:
Carcinoma, Hepatocellular/radiotherapy/*therapy;
Chemoembolization, Therapeutic/*adverse effects;
Endoscopy, Digestive System;
Gastric Fistula/*etiology;
Humans;
Liver Abscess/etiology;
Liver Diseases/*etiology;
Liver Neoplasms/radiotherapy/*therapy;
Male;
Middle Aged;
Rupture, Spontaneous/etiology;
Tomography, X-Ray Computed
- From:The Korean Journal of Gastroenterology
2011;58(3):149-152
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Transarterial chemoembolization (TACE) is recommended as one of the first line therapy for unresectable hepatocellular carcinoma (HCC). Rupture of HCC following TACE is a rare and potentially fatal complication. We report a case of hepaticoduodenal fistula with ruptured HCC and liver abscess complicated by TACE. A 52-year-old male was treated by TACE three times, followed by radiation therapy and systemic chemotherapy. 30 days after the last TACE, right upper quadrant pain of abdomen was developed. About 1 month later, computed tomography of abdomen showed ruptured HCC with debris containing liver abscess and hepaticoduodenal fistula. Esophagogastroduodenoscopy revealed hepaticoduodenal fistula and hepatic parenchyme covered with exudate. The patient was managed with supportive care, but the hepaticoduodenal fistula persisted.
